T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Kymera Therapeutics
KYMR
$9.1B
| $505M | 0.06% |
6,060,847
-98,488
| -2% | -$7.8M |
|
252
Atmos Energy
ATO
$29.9B
| $502M | 0.06% |
2,715,107
-3,881,957
| -59% | -$686M |
|
253
Boston Scientific
BSX
$65.8B
| $494M | 0.06% |
7,873,368
+416,082
| +6% | +$33.3M |
|
254
Seagate
STX
$193B
| $493M | 0.06% |
1,258,397
+95,196
| +8% | +$36.3M |
|
255
Southern Copper
SCCO
$141B
| $492M | 0.06% |
2,889,371
-788,749
| -21% | -$144M |
|
256
Rockwell Automation
ROK
$51.4B
| $490M | 0.06% |
1,364,997
-103,135
| -7% | -$40.7M |
|
257
T. Rowe Price Growth ETF
TGRT
$1.46B
| $481M | 0.06% |
12,220,083
+2,959,994
| +32% | +$125M |
|
258
Roper Technologies
ROP
$36.3B
| $481M | 0.06% |
1,358,470
-375,021
| -22% | -$138M |
|
259
Trane Technologies
TT
$106B
| $475M | 0.05% |
1,138,808
-103,223
| -8% | -$43.8M |
|
260
Alnylam Pharmaceuticals
ALNY
$36.3B
| $474M | 0.05% |
1,432,748
-270,083
| -16% | -$91.9M |
|
261
Ryanair
RYAAY
$29.5B
| $471M | 0.05% |
8,141,862
+836,973
| +11% | +$55.2M |
|
262
Equifax
EFX
$20.3B
| $471M | 0.05% |
2,613,238
-1,599,598
| -38% | -$318M |
|
263
Reliance Steel & Aluminium
RS
$20.8B
| $465M | 0.05% |
1,530,419
+595,753
| +64% | +$189M |
|
|
WCN
264
Waste Connections
WCN
$42.8B
| $458M | 0.05% |
2,817,119
+147,399
| +6% | +$24.6M |
|
265
BrightSpring Health Services
BTSG
$14.3B
| $455M | 0.05% |
10,673,661
+11,425
| +0.1% | +$460K |
|
266
Descartes Systems
DSGX
$5.84B
| $448M | 0.05% |
6,264,880
-728,252
| -10% | -$53.8M |
|
267
Encompass Health
EHC
$11.2B
| $445M | 0.05% |
4,600,549
-204,864
| -4% | -$21M |
|
268
PTC
PTC
$13.7B
| $445M | 0.05% |
3,122,184
+97,138
| +3% | +$15.4M |
|
269
Franco-Nevada
FNV
$41.4B
| $444M | 0.05% |
1,796,558
-681,417
| -27% | -$169M |
|
270
Pfizer
PFE
$140B
| $440M | 0.05% |
15,674,905
+3,200,453
| +26% | +$85.2M |
|
271
T. Rowe Price Value ETF
TVAL
$976M
| $439M | 0.05% |
12,120,749
+959,836
| +9% | +$35.4M |
|
272
Corteva
CTVA
$59.7B
| $438M | 0.05% |
5,235,932
+2,101,260
| +67% | +$158M |
|
273
Loews
L
$24.3B
| $435M | 0.05% |
4,075,878
+91,644
| +2% | +$9.81M |
|
274
Viper Energy
VNOM
$8.81B
| $428M | 0.05% |
9,112,072
-299,937
| -3% | -$12.9M |
|
275
Ovintiv
OVV
$17.5B
| $428M | 0.05% |
7,211,260
+953,456
| +15% | +$46M |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.